Intensive Care for Hepatotoxic and Neurotoxic Complications of Chemotherapy in Lung Cancer

Mualliflar

  • Nuriddin Hamzaevich Ergashev Tashkent State Medical University, Uzbekistan Muallif
  • Zoir Takhirovich Gaziev Tashkent State Medical University, Uzbekistan Muallif
  • Kamola Ravshanovna Umarova Tashkent State Medical University, Uzbekistan Muallif

Kalit so‘zlar:

lung cancer, chemotherapy, hepatotoxicity, neurotoxicity, intensive care, polyneuropathy

Abstrak

Chemotherapy remains one of the key methods for treating lung cancer; however, its use is limited by the development of toxic complications. The most clinically significant are hepatotoxic and neurotoxic reactions, which can lead to treatment interruption, reduced efficacy, and worse prognosis. This paper reviews current understanding of the pathogenesis of these complications, their clinical manifestations, and approaches to intensive care based on evidence-based medicine.

Tibbiyot muqovasi

Yuklab olishlar

Indeks havolalari

Google Scholar Zenodo OpenAIRE BASE OpenAlex Semantic Scholar DataCite

Nashr qilingan

2026-11-11

Nashr

Nomeri 11 (2026): 2026-yil, Noyabr

Bo'lim

Articles

How to Cite

Intensive Care for Hepatotoxic and Neurotoxic Complications of Chemotherapy in Lung Cancer. (2026). Tibbiyot, 11, 79-85. https://reandpub.uz/tibbiyot/article/view/1529

Foydalanilgan adabiyotlar

Чиссов В.И., Давыдов М.И. Онкология: национальное руководство. – М.: ГЭОТАР-Медиа, 2019. – 1072 с. – С. 642–658.

Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России. – М.: МНИОИ им. П.А. Герцена, 2021. – 252 с. – С. 45–52.

Верткин А.Л., Талибов О.Б. Клиническая токсикология. – М.: МЕДпресс-информ, 2020. – 368 с. – С. 210–228.

Postma T.J., Vermorken J.B. Chemotherapy-induced peripheral neuropathy // Annals of Oncology. – 2015. – Vol. 26. – P. 240–248.

Friedman S.E., Grendell J.H., McQuaid K.R. Current Diagnosis & Treatment in Gastroenterology. – New York: McGraw-Hill, 2016. – 992 p. – P. 664–672.

National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. – 2017. – P. 15–30.

ESMO Guidelines Committee. Management of toxicities from chemotherapy // Annals of Oncology. – 2020. – Vol. 31. – P. 119–134.

NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. – Version 2024. – P. 85–102.

Windebank A.J., Grisold W. Chemotherapy-induced neuropathy // Journal of the Peripheral Nervous System. – 2008. – Vol. 13. – P. 27–46.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. – Bethesda: NIH, 2022. – P. 112–130.